Condition

B-cell Non-Hodgkin Lymphoma (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Hoffmann-La Roche (1)

Collaborator

Intervention

mosunetuzumab (iv) (1)

mosunetuzumab (sc) (1)

polatuzumab vedotin (1)

rituximab (1)

tocilizumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

B-Cell Non-Hodgkin Lymphoma

Showing NaN - NaN of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS